Abametapir - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for abametapir and what is the scope of patent protection?
Abametapir
is the generic ingredient in one branded drug marketed by Hatchtech and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Abametapir has thirty-five patent family members in fifteen countries.
One supplier is listed for this compound.
Summary for abametapir
International Patents: | 35 |
US Patents: | 5 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 6 |
Patent Applications: | 489 |
What excipients (inactive ingredients) are in abametapir? | abametapir excipients list |
DailyMed Link: | abametapir at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for abametapir
Generic Entry Date for abametapir*:
Constraining patent/regulatory exclusivity:
Dosage:
LOTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for abametapir
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Reddy's Laboratories Limited | Phase 2 |
Hatchtech Pty Ltd | Phase 2 |
Syneos Health | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for abametapir
US Patents and Regulatory Information for abametapir
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for abametapir
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2933081 | COMPOSITION PEDICULICIDE (PEDICULICIDAL COMPOSITION) | ⤷ Try a Trial |
Brazil | PI0412544 | métodos de inibição de eclosão de ovo de um ectoparasito, de tratamento ou prevenção de infestação por ectoparasito em hospedeiro e de identificação de composto inibidor da eclosão de ovo de ectoparasito, respectivas composições e usos de agente quelante de metal e de pelo menos um inibidor de metaloprotease | ⤷ Try a Trial |
Eurasian Patent Organization | 031732 | ПЕДИКУЛИЦИДНАЯ КОМПОЗИЦИЯ (PEDICULICIDAL COMPOSITION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |